TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
UroMedical Halland AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,096
|
2,057
|
1,753 |
| Financial expenses |
1,037
|
0
|
0 |
| Earnings before taxes |
-645
|
609
|
443 |
| EBITDA |
409
|
597
|
447 |
| Total assets |
710
|
1,297
|
1,777 |
| Current assets |
581
|
1,243
|
1,694 |
| Current liabilities |
325
|
145
|
628 |
| Equity capital |
334
|
1,100
|
1,097 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
12
|
12
|
12 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
47.0%
|
84.8%
|
61.7% |
| Turnover per employee |
175
|
171
|
146 |
| Profit as a percentage of turnover |
-30.8%
|
29.6%
|
25.3% |
| Return on assets (ROA) |
55.2%
|
47.0%
|
24.9% |
| Current ratio |
178.8%
|
857.2%
|
269.7% |
| Return on equity (ROE) |
-193.1%
|
55.4%
|
40.4% |
| Change turnover |
110
|
299
|
141 |
| Change turnover % |
6%
|
17%
|
9% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.